Cue Biopharma, Inc. (FRA:1UC)
Germany · Delayed Price · Currency is EUR 0.5380
+0.0070 (1.32%)
At close: Nov 28, 2025
Cue Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -37.68 | -40.67 | -50.73 | -53.01 | -44.16 | -44.78 | Upgrade |
Depreciation & Amortization | 2.33 | 2.35 | 3.44 | 1.81 | 1.26 | 1.06 | Upgrade |
Other Amortization | 0.04 | 0.04 | 0.04 | 0.03 | - | - | Upgrade |
Loss (Gain) From Sale of Assets | 0.06 | -0.09 | 0.16 | 0 | -0.02 | - | Upgrade |
Loss (Gain) From Sale of Investments | -0.18 | - | -0.23 | -0.32 | -0 | 0.08 | Upgrade |
Stock-Based Compensation | 5.7 | 6.85 | 8.18 | 9.5 | 11.52 | 10.48 | Upgrade |
Other Operating Activities | -0.17 | 0.13 | 0.13 | -0.17 | -3.04 | -4.77 | Upgrade |
Change in Accounts Receivable | 2.77 | 0.75 | -1.64 | 3.09 | -1.73 | -0.66 | Upgrade |
Change in Accounts Payable | -4.13 | -0.68 | 0.77 | 0.08 | 0.52 | 0.74 | Upgrade |
Change in Unearned Revenue | 7.56 | -2.03 | 2.11 | -0.65 | -7.97 | 0.5 | Upgrade |
Change in Other Net Operating Assets | -5.92 | -2.97 | -2.18 | -2.17 | 4.79 | 4.85 | Upgrade |
Operating Cash Flow | -29.64 | -36.33 | -39.96 | -41.81 | -38.84 | -32.49 | Upgrade |
Capital Expenditures | -0.18 | -0.07 | - | -0.17 | -0.91 | -0.6 | Upgrade |
Sale of Property, Plant & Equipment | 0.02 | 0.1 | 0 | 0.01 | 0.02 | - | Upgrade |
Investment in Securities | -6.79 | - | 25 | -24.45 | 10 | 5.05 | Upgrade |
Investing Cash Flow | -6.95 | 0.03 | 25 | -24.61 | 9.11 | 4.46 | Upgrade |
Long-Term Debt Issued | - | - | - | 10 | - | - | Upgrade |
Long-Term Debt Repaid | - | -4 | -2 | - | - | - | Upgrade |
Net Debt Issued (Repaid) | -4 | -4 | -2 | 10 | - | - | Upgrade |
Issuance of Common Stock | 19.87 | 14.24 | 13.86 | 39.3 | 19.98 | 58.89 | Upgrade |
Repurchase of Common Stock | - | - | - | -0.2 | -0.75 | -0.27 | Upgrade |
Other Financing Activities | - | - | - | 4.56 | - | - | Upgrade |
Financing Cash Flow | 15.87 | 10.24 | 11.86 | 53.66 | 19.23 | 58.61 | Upgrade |
Net Cash Flow | -20.72 | -26.05 | -3.1 | -12.76 | -10.5 | 30.58 | Upgrade |
Free Cash Flow | -29.82 | -36.4 | -39.96 | -41.98 | -39.75 | -33.09 | Upgrade |
Free Cash Flow Margin | -419.97% | -391.89% | -727.89% | -3371.65% | -266.04% | -1049.01% | Upgrade |
Free Cash Flow Per Share | -0.34 | -0.65 | -0.87 | -1.18 | -1.27 | -1.15 | Upgrade |
Cash Interest Paid | 0.32 | 0.67 | 1 | 0.57 | - | - | Upgrade |
Cash Income Tax Paid | - | - | - | - | 0.5 | - | Upgrade |
Levered Free Cash Flow | -14.68 | -20.36 | -19.91 | -21.09 | -20.32 | -13.58 | Upgrade |
Unlevered Free Cash Flow | -14.43 | -19.9 | -19.17 | -20.68 | -20.32 | -13.58 | Upgrade |
Change in Working Capital | 0.27 | -4.93 | -0.93 | 0.36 | -4.39 | 5.43 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.